Environmental Factors That Affect the Sanitary and Nutritional Variability of Raw Milk in Dual Purpose Livestock Systems of Colombian Orinoquia

Milk is the natural food with the highest biological quality for the human population and its production can be affected by several sanitary factors and management conditions. With the objective of identifying influence factors on milk compositional and sanitary quality in a region with wide productive potential in the Colombian Orinoquia, an experiment was carried out in two contrasting climatic seasons. For the milk compositional analysis, samples of daily production from 30 dual-purpose systems were analyzed. Similarly, the udder sanitary status of 300 cows was studied using the California Mastitis Test (CMT). Data analysis included mixed models, Pearson correlations, frequency tables, and the Kruskal–Wallis test. The results showed that the total daily milk production of the farm and the season influenced the milk compositional quality. The farms with milk productions lower than 100 kg/day presented the highest levels of protein, lactose, solid non-fat (SNF), and density, while in the rainy season, the milk quality was higher compared to the dry season. The CMT test indicated that only 7.6% of the evaluated mammary quarters presented two or more degrees of positivity. There is an opportunity to improve the milk compositional quality by improving the nutritional offer for animals during the year. The low CMT positivity indicates that, in the calf-at-foot milking system, the presence of subclinical mastitis is not a determining variable in milk production

Desafíos y tendencias para la perdurabilidad de las organizaciones en escenarios de incertidumbre

This research book contains chapters that analyze the development and strengthening of organizations to become increasingly competitive, facing the opportunities of new business models in the global context. Among the topics discussed are: solutions to problems inherent to the quality of life, productivity, competitiveness, and sustainable development of organizations through innovation, marketing, training, and human talent, among others.Este libro de investigación presenta capítulos que analizan el desarrollo y el fortalecimiento de las organizaciones para hacerse cada vez más competitivas frente a las oportunidades de nuevos modelos de negocios en contextos glocales. Entre los temas presentados se abordan soluciones a problemáticas inherentes a la calidad de vida, la productividad, la competitividad y el desarrollo sostenible de las organizaciones, mediante la innovación, el marketing, la formación y el talento humano, entre otros.Este livro de pesquisa apresenta capítulos que analisam o desenvolvimento e o fortalecimento das organizações para se tornarem cada vez mais competitivas frente às oportunidades de novos modelos de negócios em contextos glocais. Entre os temas apresentados se abordam soluções a problemáticas inerentes à qualidade de vida, a produtividade, a competitividade e o desenvolvimento sustentável das organizações, mediante a inovação, o marketing, a formação e o talento humano, entre outros

Las organizaciones desde una mirada del desarollo sostenible

En el presente libro se articulan en dos líneas, a saber, las organizaciones desde la región y las organizaciones desde el emprendimiento y la gestión. En la primera se analizan diferentes temáticas que dejan ver el uso adecuado de la ciencia y la tecnología, reconociendo el rol de los sectores tanto público como privado y de la sociedad civil en el desarrollo, productividad y competitividad de las organizaciones, por lo que se tienen temáticas como normas internacionales, emprendimiento, tasa representativa del mercado, direccionamiento estratégico en el sector de obras civiles, precios internos y externos del tipo de cambio, que permitan comprender la dinámica contemporánea de las organizaciones, a partir de las experiencias de los diferentes actores que participan en escenarios inclusivos, con el propósito de evidenciar los elementos de competitividad y perdurabilidad que contribuyen a la internacionalización organizacional.La segunda línea trata de las organizaciones en la región, donde se muestran resultados de investigaciones, como las tendencias mundiales en el sector funerario, estrategias de innovación empresarial y responsabilidad social empresarial para Mipymes. Usos agroindustriales de la hoja de coca, factores de competitividad en la ganadería, en el sector metalmecánico, redes socio institucionales en el sector lácteo, imagen comercial de empresario, estrategia de encadenamiento, patios productivos, aplicación del modelo desing thinking, gestión del conocimiento en Mipymes industriales, ecosistema de emprendimiento, microempresas sostenibles, territorios de paz que dejan ver las nuevas tendencias y temáticas de creatividad e innovación para fortalecer la pedagogía, las competencias, las redes de emprendimiento a través de las herramientas, modelos y estructuras de los esquemas emprendedores, que permitan la continua evolución de los mercados emergentes y sus diferentes actores

Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of patients with different forms of chronic arthritis who are treated with biologics. Using this registry, we have analyzed patient switching of TNF antagonists. The cumulative discontinuation rate was calculated using the actuarial method. The log-rank test was used to compare survival curves, and Cox regression models were used to assess independent factors associated with discontinuing medication. Between February 2000 and September 2004, 4,706 patients were registered in BIOBADASER, of whom 68% had rheumatoid arthritis, 11% ankylosing spondylitis, 10% psoriatic arthritis, and 11% other forms of chronic arthritis. One- and two-year drug survival rates of the TNF antagonist were 0.83 and 0.75, respectively. There were 488 patients treated with more than one TNF antagonist. In this situation, survival of the second TNF antagonist decreased to 0.68 and 0.60 at 1 and 2 years, respectively. Survival was better in patients replacing the first TNF antagonist because of adverse events (hazard ratio (HR) for discontinuation 0.55 (95% confidence interval (CI), 0.34-0.84)), and worse in patients older than 60 years (HR 1.10 (95% CI 0.97-2.49)) or who were treated with infliximab (HR 3.22 (95% CI 2.13-4.87)). In summary, in patients who require continuous therapy and have failed to respond to a TNF antagonist, replacement with a different TNF antagonist may be of use under certain situations. This issue will deserve continuous reassessment with the arrival of new medications. © 2006 Gomez-Reino and Loreto Carmona; licensee BioMed Central Ltd

Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

Background: The optimal treatment of anastomotic leak after rectal cancer resection is unclear. This worldwide cohort study aimed to provide an overview of four treatment strategies applied. Methods: Patients from 216 centres and 45 countries with anastomotic leak after rectal cancer resection between 2014 and 2018 were included. Treatment was categorized as salvage surgery, faecal diversion with passive or active (vacuum) drainage, and no primary/secondary faecal diversion. The primary outcome was 1-year stoma-free survival. In addition, passive and active drainage were compared using propensity score matching (2: 1). Results: Of 2470 evaluable patients, 388 (16.0 per cent) underwent salvage surgery, 1524 (62.0 per cent) passive drainage, 278 (11.0 per cent) active drainage, and 280 (11.0 per cent) had no faecal diversion. One-year stoma-free survival rates were 13.7, 48.3, 48.2, and 65.4 per cent respectively. Propensity score matching resulted in 556 patients with passive and 278 with active drainage. There was no statistically significant difference between these groups in 1-year stoma-free survival (OR 0.95, 95 per cent c.i. 0.66 to 1.33), with a risk difference of -1.1 (95 per cent c.i. -9.0 to 7.0) per cent. After active drainage, more patients required secondary salvage surgery (OR 2.32, 1.49 to 3.59), prolonged hospital admission (an additional 6 (95 per cent c.i. 2 to 10) days), and ICU admission (OR 1.41, 1.02 to 1.94). Mean duration of leak healing did not differ significantly (an additional 12 (-28 to 52) days). Conclusion: Primary salvage surgery or omission of faecal diversion likely correspond to the most severe and least severe leaks respectively. In patients with diverted leaks, stoma-free survival did not differ statistically between passive and active drainage, although the increased risk of secondary salvage surgery and ICU admission suggests residual confounding

Stoma-free Survival After Rectal Cancer Resection With Anastomotic Leakage: Development and Validation of a Prediction Model in a Large International Cohort.

Objective:To develop and validate a prediction model (STOMA score) for 1-year stoma-free survival in patients with rectal cancer (RC) with anastomotic leakage (AL).Background:AL after RC resection often results in a permanent stoma.Methods:This international retrospective cohort study (TENTACLE-Rectum) encompassed 216 participating centres and included patients who developed AL after RC surgery between 2014 and 2018. Clinically relevant predictors for 1-year stoma-free survival were included in uni and multivariable logistic regression models. The STOMA score was developed and internally validated in a cohort of patients operated between 2014 and 2017, with subsequent temporal validation in a 2018 cohort. The discriminative power and calibration of the models' performance were evaluated.Results:This study included 2499 patients with AL, 1954 in the development cohort and 545 in the validation cohort. Baseline characteristics were comparable. One-year stoma-free survival was 45.0% in the development cohort and 43.7% in the validation cohort. The following predictors were included in the STOMA score: sex, age, American Society of Anestesiologist classification, body mass index, clinical M-disease, neoadjuvant therapy, abdominal and transanal approach, primary defunctioning stoma, multivisceral resection, clinical setting in which AL was diagnosed, postoperative day of AL diagnosis, abdominal contamination, anastomotic defect circumference, bowel wall ischemia, anastomotic fistula, retraction, and reactivation leakage. The STOMA score showed good discrimination and calibration (c-index: 0.71, 95% CI: 0.66-0.76).Conclusions:The STOMA score consists of 18 clinically relevant factors and estimates the individual risk for 1-year stoma-free survival in patients with AL after RC surgery, which may improve patient counseling and give guidance when analyzing the efficacy of different treatment strategies in future studies